Cases 1 - 10 of 45
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2024cv00587
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2024cv00565
Plaintiff:
Exelixis, Inc.
Defendant:
Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Cipla Ltd. et al
as 1:2023cv01196
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Cipla Ltd., Cipla USA Inc. and Invagen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hikma Pharmaceuticals USA Inc. v. Cipla USA, Inc. et al
as 1:2023cv01157
Plaintiff:
Hikma Pharmaceuticals USA Inc.
Defendant:
Cipla USA, Inc. and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mitsubishi Tanabe Pharma Corporation v. Cipla USA, Inc. et al
as 1:2023cv00759
Plaintiff:
Mitsubishi Tanabe Pharma Corporation
Defendant:
Cipla USA, Inc. and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Cipla Limited et al
as 1:2023cv00389
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2023cv00287
Plaintiff:
Exelixis, Inc.
Defendant:
Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
as 1:2022cv00552
Plaintiff:
Cipla USA, Inc.
Defendant:
Ipsen Biopharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2022cv00162
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Cipla Limited et al
as 1:2021cv01229
Plaintiff:
UCB, Inc., UCB Biopharma SRL, Hananja EHF and others
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
